Fiber cell defects in a human β-amyloid (Aβ) transgenic mouse model of Alzheimer pathophysiology in the lens

被引：0
|
作者：
Frederikse, PH [1 ]
Li, G [1 ]
Ren, XO [1 ]
Qazi, S [1 ]
Farnsworth, P [1 ]
机构：
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4801
引用
收藏
页码：U1351 / U1351
页数：1
相关论文
共 50 条
  • [31] Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease
    Kallhoff, Verena
    Peethumnongsin, Erica
    Zheng, Hui
    MOLECULAR NEURODEGENERATION, 2007, 2 (1)
  • [32] Copper Complexing with Tetrathiomolybdate Suppresses Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
    Quinn, Joseph F.
    Domes, Christopher
    Harris, Christopher
    Brewer, George
    Ralle, Martina
    Wadsworth, Teri
    NEUROLOGY, 2009, 72 (11) : A52 - A53
  • [33] Expression of Neprilysin in Skeletal Muscle Reduces Amyloid Burden in a Transgenic Mouse Model of Alzheimer Disease
    Liu, Yinxing
    Studzinski, Christa
    Beckett, Tina
    Guan, Hanjun
    Hersh, Matthew A.
    Murphy, M. Paul
    Klein, Ronald
    Hersh, Louis B.
    MOLECULAR THERAPY, 2009, 17 (08) : 1381 - 1386
  • [34] Baicalein reduces β-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer's disease transgenic mouse model
    Zhang, She-Qing
    Obregon, Demian
    Ehrhart, Jared
    Deng, Juan
    Tian, Jun
    Hou, Huayan
    Giunta, Brian
    Sawmiller, Darrell
    Tan, Jun
    JOURNAL OF NEUROSCIENCE RESEARCH, 2013, 91 (09) : 1239 - 1246
  • [35] Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease
    Domnitz, SB
    Robbins, EM
    Hoang, AW
    Garcia-Alloza, M
    Hyman, BT
    Rebeck, GW
    Greenberg, SM
    Bacskai, BJ
    Frosch, MP
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2005, 64 (07): : 588 - 594
  • [36] β-amyloid reductions in brain, plasma and CSF of a transgenic mouse model of Alzheimer's disease with a γ-secretase inhibitor
    Barten, DM
    Guss, VL
    Corsa, JA
    Loo, AT
    Hansel, SB
    Zheng, M
    Munoz, B
    Srinivasan, K
    Robertson, B
    Hendrick, JP
    Anderson, JJ
    Verdoorn, TA
    Roberts, SB
    Felsenstein, KM
    Smith, DW
    NEUROBIOLOGY OF AGING, 2004, 25 : S82 - S82
  • [37] Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis
    Xu, Guilian
    Stevens, Stanley M., Jr.
    Moore, Brenda D.
    McClung, Scott
    Borchelt, David R.
    HUMAN MOLECULAR GENETICS, 2013, 22 (14) : 2765 - 2774
  • [38] Amyloid Plaque Imaging with a Targeted MRI Contrast Agent in a Transgenic Mouse Model of Alzheimer's Disease
    Xiong, Yongjie
    Qu, Yi
    Min, Zhe
    Wu, Jun
    Zhang, Suming
    Xue, Zheng
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2022, 17 : 927 - 936
  • [39] A Copper-Lowering Strategy Attenuates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
    Quinn, Joseph F.
    Harris, Christopher J.
    Cobb, Katherine E.
    Domes, Christopher
    Ralle, Martina
    Brewer, George
    Wadsworth, Teri L.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 903 - 914
  • [40] Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease
    Yuksel, Melike
    Biberoglu, Kevser
    Onder, Seda
    Akbulut, K. Gonca
    Tacal, Ozden
    BIOCHIMIE, 2018, 146 : 105 - 112
12345